2m 2m 2m 2m 2m 2m 2m
LUCID DIAGNOSTCS (LUCD)
NASDAQ
$0.48+$0.07 (+16.02%)
Price as of Nov 13, 2026 1:54 PM EST- $79.5MMarket Cap
- -61.09%1-Year Change
- Medical DevicesIndustry
LUCID DIAGNOSTCS (LUCD)
$0.48+$0.07 (+16.02%)
LUCD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.42 | ||
Change | +$0.03 (+9.15%) | ||
Open | $0.40 | ||
High | $0.43 | ||
Low | $0.38 | ||
Previous Close | $0.38 | ||
Volume | 2,358,620 | ||
30-Day Average Volume | 11,097,015 | ||
1-Week Change | 6.72% | ||
1-Month Change | -30.31% | ||
1-Year Change | -61.09% | ||
3-Year Change | -64.11% | ||
5-Year Change | -95.74% | ||
Fundamentals | |||
Shares Outstanding | 190.9M | ||
Total Assets | $27.9M | ||
Market Cap | $79.5M | ||
Enterprise Value | $78.8M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$15.6M | ||
EBIT | -$6.7M | ||
EBITDA | -$6.5M | ||
Net Working Capital | $4.3M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 66 | ||
P/B | 13 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue